ILLUSTRATUM 

An enlightened future today

OWNER

David Trevor (See Profile)

Sector

Drug Discovery

Stage

Sales, licensing phases

Country

United Kingdom


DARC Technology will allow pharma companies to see if their glaucoma or AMD drug works in of weeks instead of years

DARC is a unique biomarker allowing disease activity to be measured in glaucoma or AMD. No competition exists

Already approved as an exploratory bio marker by the FDA and MHRA, we can start selling immediately

This information is confidential, do not share or copy.

Under evaluation at least till: 16/05/2019

** PLEASE NOTE: THIS PROJECT IS NOT SEEKING CROWDFUNDING THROUGH CAPITAL CELL AND THEREFORE YOUR REVIEW WILL NOT EARN ANY CREDITS **

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2019 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar